Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

Call to improve accuracy of predictive genetic tests

12 October 2009

By Dr Jess Buxton

Appeared in BioNews 529

Companies offering 'direct-to-consumer' genetic tests to predict the risk of common conditions such as heart attack and rheumatoid arthritis should provide more information to consumers about the limitations of their services, say US scientists. Their recommendations follow the finding that several tests from two such companies gave different results for the same five individuals. Genome pioneer Craig Venter and colleagues also call for more research into the predictive power of genetic markers associated with common disease, and in a wider range of ethnic groups than the European populations studied so far.

The scientists, based at the J Craig Venter Institute in San Diego and the Scripps Translational Science Institute in La Jolla, California, sent DNA samples from five people to the US genetic testing firms Navigenics and Google-backed 23andMe. Although the raw genetic data generated by the two companies was accurate, their interpretation of the results was often very different. For seven diseases, including Crohn's disease and Type 2 diabetes, their predictions agreed for only 50 per cent or less of the five individuals.

One of the reasons for the discrepancies between the companies' results was their use of different genetic variants associated with the same disease. However, the authors point out that the findings largely reflect our current incomplete knowledge of the genetic factors that play a role in the risk of future disease. 'Even this little study shows how early and primitive we are in our understanding of the human genome', Venter told Reuters news service. Scientists have uncovered more than 1000 genetic variations associated with diseases and other human traits, but it is believed many more remain to be found, and their interactions with each other and with non-genetic factors such as diet and lifestyle are still poorly understoood.

The authors make nine recommendations, including a call for companies to tell consumers exactly what proportion of the estimated genetic contribution for a disease is currently known, and to agree to use the same genetic markers in their tests. They also call upon the wider genetics community to carry out more research into how people use personal genomic data to improve health; more long term studies assessing the accuracy of predictive tests; and more genetic research in non-European populations.

Other articles in last week's Nature reviewed the successes of the 'genome-wide association' studies (GWAS) carried out to date - the large-scale projects used to identify many of the genetic variations associated with disease - and what still remains to be done to understand the genetic basis of common conditions. It is essential that the future benefits of human genetic research are not oversold, and inadequate predictive tests are not offered prematurely to consumers.

This crucial issue will be considered on Wednesday 18 November 2009 at Does Genetics Matter? Help, Hype and the New Horizon of Epigenetics, the annual conference of the charity that publishes BioNews, the Progress Educational Trust (PET). This one-day event will also review past successes in the care and treatment of families affected by monogenic disorders, and look at recent developments in the emerging field of epigenetics, which promises to shed light on the interplay between genetic factors and environmental influences.


Dr Jess Buxton is Contributing Editor at BioNews and a Trustee at the charity that publishes it, the Progress Educational Trust (PET). She is co-author of The Rough Guide to Genes and Cloning (buy this book from Amazon UK) and Human Fertilisation and Embryology: Reproducing Regulation (buy this book from Amazon UK).

SOURCES & REFERENCES
Nature | 08 October 2009
 
Nature | 08 October 2009
 
Nature | 08 October 2009
 
Reuters | 07 October 2009
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

25 July 2011 - by Heidi Colleran 
Ethnic and racial minorities are in danger of missing out on future medical advances - based on genetic research - because they are under-represented in basic studies, says a review published in Nature Genetics by a team of geneticists from Stanford University and University of California, San Francisco...
09 August 2010 - by Chris Chatterton 
The Human Genome Commission (HGC) has published a new ‘Common Framework of Principles’ for direct-to-consumer (DTC) genetic tests on 4 August....
08 March 2010 - by Dr Rachael Panizzo 
A genetic risk score based on several genetic markers associated with cardiovascular disease (CVD) does not improve the prediction of CVD risk, research published in the Journal of the American Medical Association has suggested...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation